Bloomberg Triple Take Three hosts, One topic, three takes. "Bloomberg Triple Take" takes one issue affecting global markets and the economy and splits it into three angles. The program hosted by Caroline Hyde, Romaine Bostick and Taylor Riggs uses the power of the Bloomberg Terminal, Bloomberg Intelligence and Bloomberg News to provide analysis and data that can't be found anywhere else.
Bloomberg Businessweek Insight and analysis of top stories from our award winning magazine "Bloomberg Businessweek". Listen
The Breakdown: Evergrande Once one of China’s most successful developers, Evergrande has been labeled a defaulter and is more than $300 billion in debt. Now it's racing to restructure as bondholders warn of possible enforcement action.
Subscriber OnlyBusinessPrognosisAstra-Oxford Shot Is Key to Escaping Pandemic for Many NationsVaccine makes up 40% of low-, middle-income countries’ supplyWorld awaits Astra data after strong Pfizer, Moderna resultsOxford-AstraZeneca Vaccine `Much Easier to Distribute': Lancet EditorByJames Paton and Suzi Ring+FollowNovember 22, 2020, 5:00 AM UTCSign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.Trial successes from Pfizer Inc. and Moderna Inc. have buoyed hopes that a Covid-19 vaccine is coming soon. But much of the world, outside of rich nations like the U.S., is counting on another company’s shot to escape the crisis.
